Ithas been approved for the treatment of eight different diseases, including certain types of leukemia and gastrointestinal stromal tumors (GIST).38 Imatinib is a tyrosine kinase inhibitor that targets specific abnormal protein kinases involved in the growth and proliferation of cancer cells. The gene discussed is WEE1; the disease is gastrointestinal stromal tumor.